Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in lung adenocarcinoma

OBJECTIVES: Third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors were recently reported to be effective as adjuvant therapy for resected lung adenocarcinoma (ADC) harbouring common EGFR mutations. However, whether the EGFR mutation is a direct risk factor for postopera...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumura, Yuki, Hayasaka, Kazuki, Ohira, Tetsuya, Shiono, Satoshi, Abe, Jiro, Notsuda, Hirotsugu, Sakurada, Akira, Suzuki, Hiroyuki, Okada, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thoracic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640389/
https://www.ncbi.nlm.nih.gov/pubmed/37930012
http://dx.doi.org/10.1093/icvts/ivad174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640389/
https://www.ncbi.nlm.nih.gov/pubmed/37930012
http://dx.doi.org/10.1093/icvts/ivad174

Ejemplares similares